Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:55 2026-07-30 EDT			5-day change	1st Jan Change
2,609.65 ^INR	-0.67%		+2.30%	+5.61%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	4.65B	-	-	-	-
ELI LILLY AND COMPANY	1,079B		A
JOHNSON & JOHNSON	640B		BBB
ABBVIE INC.	465B		AA	-
ROCHE HOLDING AG	353B		AA
NOVARTIS AG	301B		AAA
ASTRAZENECA PLC	271B		A
NOVO NORDISK A/S	228B		A
AMGEN INC.	209B		A
GILEAD SCIENCES, INC.	165B		AA
PFIZER INC.	143B		A
BRISTOL-MYERS SQUIBB COMPANY	129B		A
VERTEX PHARMACEUTICALS INCORPORATED	123B		AA
SANOFI	109B		AA
GSK PLC	106B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.98B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.98B		AA
BAYER AG	53.32B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.55B		AA
HALEON PLC	44.43B		AA
Average	230.15B		AA
Weighted average by Cap.			AA